Cargando…

Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma that affects B lymphocytes. It can develop in the lymph nodes and can be localized or generalized. Despite DLBCL being considered potentially curable, little research has been conducted on the relationship betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hao, Sun, Hui-Cong, Ouyang, Gui-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631411/ https://www.ncbi.nlm.nih.gov/pubmed/37946782 http://dx.doi.org/10.12998/wjcc.v11.i29.7075

Ejemplares similares

T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma
por: Wu, Hao, et al.
Publicado: (2022)

Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression
por: Jovanovic, Marina, et al.
Publicado: (2019)

Helicobacter pylori eradication treatment for primary gastric diffuse large B-cell lymphoma: A single-center analysis
por: Saito, Makoto, et al.
Publicado: (2023)

Clinical implications of interleukins-31, 32, and 33 in gastric cancer
por: Liu, Qing-Hua, et al.
Publicado: (2022)

Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker
por: Vazquez Guillamet, M. Cristina, et al.
Publicado: (2021)

Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease
por: Lv, Jia-Jia, et al.
Publicado: (2021)

Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study
por: Fatima, Syeda Sadia, et al.
Publicado: (2017)

Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
por: Wang, Gang, et al.
Publicado: (2019)

Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma
por: An, Yang, et al.
Publicado: (2018)

Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis
por: Tavakolpour, Soheil
Publicado: (2016)

Candida albicans Morphogenesis Is Not Required for Macrophage Interleukin 1β Production
por: Wellington, Melanie, et al.
Publicado: (2012)

Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma
por: Lv, Xiao, et al.
Publicado: (2016)

Accuracy for Mortality Prediction With Additive Biomarkers Including Interleukin-6 in Critically Ill Patients: A Multicenter Prospective Observational Study
por: Yamamoto, Ryo, et al.
Publicado: (2021)

Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta
Publicado: (1995)

Interleukin-35 Induces Regulatory B Cells that Suppress CNS Autoimmune Disease
por: Wang, Ren-Xi, et al.
Publicado: (2014)

Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19(+) B cells in patients with ankylosing spondylitis
por: Zhang, Yu, et al.
Publicado: (2022)

Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritis
por: Suyasa, I Ketut, et al.
Publicado: (2017)

Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma
por: Takeda, Atsunobu, et al.
Publicado: (2020)

Interleukin-35 on B cell and T cell induction and regulation
por: Huang, Ai, et al.
Publicado: (2017)

Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells
por: Zheng, Xing-Feng, et al.
Publicado: (2018)

Effect of interleukin 21 and its receptor on CD8(+) T cells in the pathogenesis of diffuse large B-cell lymphoma
por: CHA, ZHANSHAN, et al.
Publicado: (2014)

Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013)

The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells.
por: Zimmerman, M J, et al.
Publicado: (1998)

Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma
por: Carreras, Joaquim, et al.
Publicado: (2023)

Interleukin 10 inhibits transforming growth factor-beta (TGF-beta) synthesis required for osteogenic commitment of mouse bone marrow cells
Publicado: (1994)

Roles of interleukins (interleukin-18 and interleukin-17a) and transforming growth factor-beta markers in the pathogenesis of diabetic kidney diseases
por: Mezher, Maysam Adnan, et al.
Publicado: (2023)

Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells
por: Kwaśniak, Konrad, et al.
Publicado: (2019)

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma
por: Yang, Haiyan, et al.
Publicado: (2022)

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
por: Thudium Mueller, Karen, et al.
Publicado: (2021)

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma
por: Bartlett, Nancy L., et al.
Publicado: (2023)

Elevated levels of interleukin‐35 and interleukin‐37 in adult patients with obstructive sleep apnea
por: Chen, Bi, et al.
Publicado: (2021)

Duodenal-type follicular lymphoma more than 10 years after treatment intervention: A retrospective single-center analysis
por: Saito, Makoto, et al.
Publicado: (2022)

Interleukin-10 and Transforming Growth Factor Beta1 Gene Polymorphisms in Chronic Heart Failure
por: Mohammad, Jafar Mahmoudi, et al.
Publicado: (2019)

Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
por: Luo, Zhengkang, et al.
Publicado: (2021)

Interleukin-10 Producing Regulatory B Cells Transformed CD4(+)CD25(−) Into Tregs and Enhanced Regulatory T Cells Function in Human Leprosy
por: Tarique, Mohd., et al.
Publicado: (2018)

Cardiometabolic risk factors in young Indian men and their association with parameters of insulin resistance and beta-cell function
por: Gupta, Yashdeep, et al.
Publicado: (2022)

Expression of Foxp3 and interleukin-7 receptor and clinicopathological characteristics of patients with diffuse large B-cell lymphoma
por: Zhao, Yan, et al.
Publicado: (2020)

Association of Early Beta-Blocker Exposure and Functional Outcomes in Critically Ill Patients With Moderate to Severe Traumatic Brain Injury: A Transforming Clinical Research and Knowledge in Traumatic Brain Injury Study
por: Kelly-Hedrick, Margot, et al.
Publicado: (2023)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_obj5pg9cjt1bhn4vp76e74sgmi